Cite
MLA Citation
A. Kumar et al.. “A PILOT STUDY OF BRENTUXIMAB VEDOTIN AND AVD CHEMOTHERAPY FOLLOWED BY 20 GY INVOLVED‐SITE RADIOTHERAPY IN EARLY STAGE, UNFAVORABLE RISK HODGKIN LYMPHOMA.” Hematological oncology, vol. 35, n.d., pp. 171–172. http://access.bl.uk/ark:/81055/vdc_100047339759.0x00001a